Temperature Controlled Packaging Pharmaceutical Market Analysis

Global Temperature-controlled Packaging for Pharmaceutical Market Overview

Temperature-controlled Packaging for Pharmaceutical Market Size was valued at USD 10,946 Million in 2023. The Global Temperature-controlled Packaging for Pharmaceutical industry is projected to grow from USD 10,946 Million in 2023 to USD 24,130 Million by 2032, exhibiting a compound annual growth rate (CAGR) of 9.2% during the forecast period (2024 - 2032).

Growth in the Pharmaceutical Industry, Adoption of smarter cold chain technology, and Various government initiatives to boost their regional pharmaceutical industry are driving the Temperature-controlled Packaging for Pharmaceutical Market.

Temperature-controlled packaging for pharmaceuticals, as the name suggests a form of packaging that offers a specific range of temperature to maintain and secure the quality and integrity of the range of pharmaceutical products. Temperature-controlled packaging provides the required necessary protection to the pharmaceuticals throughout transportation. The ability of temperature-controlled packaging to offer an extensive range of packaging temperatures for pharmaceutical products raises its demand and popularity among pharmaceutical brand owners. This report has segmented the Temperature-controlled Packaging for Pharmaceutical Market based on product, type, temperature range, payload capacity, medicine type, use, and end-use industry.

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Temperature-controlled Packaging for Pharmaceutical Market Trends

• 
  

  Growth In The Pharmaceutical Industry Supplementing Sales To The Significant Extent

  
  

The growing demand for packaging in the pharmaceutical industry has aided the growth of temperature-controlled packaging for the pharmaceutical market. Temperature-controlled packaging for pharmaceuticals is designed to maintain the proper temperature of sensitive products. Such packaging solutions are primarily used in the healthcare industry for the transportation and storage of temperature-sensitive products in a controlled temperature environment.

A major focus area of many national and international organizations, such as the World Health Organization (WHO), is the reduction of vaccine wastage. As a part of this, several programs are organized to monitor vaccine wastage at the country level. The objectives of such programs are proper packaging, handling, and transportation of vaccines. Such consciousness triggers the demand for temperature-controlled packaging for pharmaceuticals in the healthcare sector. The growth in medical tourism across the globe is another major reason for the pharmaceutical industry's growth. In Asia-Pacific, countries such as Thailand are recognized as one of the leading destinations in the world for their growing number of well-equipped hospitals with low cost and high-quality treatment facilities and a wide range of services. The Thai government announced a ten-year strategic plan to be implemented from 2016-to 2025 to turn Thailand into a hub for wellness, medical services, academics, and products. The growth of the pharmaceutical industry is also attributed to the rising import and export of pharmaceutical products across the globe, and the rising number of outsourced clinical trials to Asian countries, especially in China, South Korea, Taiwan, and others.

Adoption Of Smarter Cold Chain Technology

The pharmaceutical manufacturers have identified a greater need for product temperature assured distribution, including material handling. Their drug portfolios have evolved with the development and more complex biotechnology drugs from the traditional small molecule/chemical pharmaceutical products. Such complex biotechnological drugs require a 15 – 25°C range of high-temperature control. The drug manufacturers select an appropriate temperature for packing pharmaceutical products, which protects the shipment for 96 hours. The third-party logistic (3PL) companies ship the products at various temperature conditions, often affecting their quality. To avoid this, the pharma manufacturers adopt smarter cold chain technology, which helps monitor the temperature based on the product requirements, ensuring product safety and integrity. Leading pharmaceutical companies are developing advanced temperature-controlled supply chains. The new temperature control packaging solutions will enable the manufacturers to maintain the required temperature of the products to retain their life. Hence, the increased use of temperature control packaging in the pharmaceutical industry will lead to the growth of the Temperature-controlled Packaging for Pharmaceutical Market during the forecast period.

Temperature-controlled Packaging for Pharmaceutical Market Segment Insights:

Global Temperature-controlled Packaging for Pharmaceutical Product Insights

Based on product, the Temperature-controlled Packaging for Pharmaceutical Market is segmented into Shippers and Containers. The Shippers product segment is expected to dominate the global temperature-controlled packaging for the pharmaceutical market during the forecast period. Cold shipment boxes protect temperature-sensitive products throughout transport and delivery, and shippers keeps refrigerated and frozen. Corrugated and foam-only expanded polystyrene (EPS) shippers provide safety and economy without leaching dangerous chemicals during use or disposal. Polyurethane (PUR) shippers insulate better than equivalent-thickness EPS containers, while vacuum insulated panel (VIP) shippers prevent heat damage during long shipping. They're used to keeping things fresh and effective as part of the cold chain. Parcel shipping systems are another name for shippers. These may transport temperature-sensitive cargo with a volume ranging from 4 to 100 liters.

Figure 1: Temperature-controlled Packaging for Pharmaceutical Market, by Product, 2023 & 2032 (USD Million)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Temperature-controlled Packaging for Pharmaceutical Type Insights

Based on type, the Temperature-controlled Packaging for Pharmaceutical Market is segmented into Active System and Passive System. The Passive System type segment is expected to dominate the global temperature-controlled packaging for the pharmaceutical market during the forecast period. Standard water-based refrigerants and insulated containers/shippers are considered passive systems, as are specialized refrigerants or phase-change materials. Passive containers are appropriate for usage in a regulated room temperature (CRT) environment or as general protection for low-risk cargo. Inside an insulated enclosure, a passive container provides a temperature-controlled environment. This can be done with or without thermostatic regulation and with or without using a finite amount of pre-conditioned coolants such as chilled or frozen gel packs, phase transition materials, or dry ice. Polystyrene, polyurethane, or vacuum insulated panels are commonly used to insulate passive containers. Many are designed to maintain a specific temperature for a set payload capacity for up to 96 hours.

Temperature-controlled Packaging for Pharmaceutical Temperature Range Insights

Based on Temperature Range, the Temperature-controlled Packaging for Pharmaceutical Market is segmented into -20°C and Below, -20°C to 0°C, 2°C to 8°C, 8°C to 25°C, and Above 25°C. The 8°C to 25°C temperature range segment is expected to dominate the global temperature-controlled packaging for the pharmaceutical market during the forecast period. When working in the pharmaceutical industry, maintaining the proper cool temperature for the storage of specific items is critical. Medical product testing, medicine stability, and the safeguarding of high-value medical items all require high-cool storage. Pharmaceutical firms who want to increase the quality of their product while expanding their storage capacity may consider investing in cool storage. Storage chambers provide high-value controlled cooling environments for a range of products and can be suited to meet the needs of your industry. Large portion/range of pharmaceutical items pack, transport, and store in the given temperature range.

Temperature-controlled Packaging for Pharmaceutical Payload Capacity Insights

Based on payload capacity, the Temperature-controlled Packaging for Pharmaceutical Market is segmented into Up to 10 L, 10 L - 20 L, 20 L - 40 L, 40 L - 150 L, and Above 150 L. The Up to 10 L payload capacity segment is expected to dominate the global temperature-controlled packaging for the pharmaceutical market during the forecast period. In up to 10 L, the base is designed with the choice of a 100mm-high base or four fixed 150mm-high legs and four tray shelves, each with a 10 L capacity with the Height of base/legs (mm) (1,950 / 2,000), Width (500) and insulated bag version in several sizes or insulated backpack. Possibility to create bespoke and personalized insulated shippers and containers for your marketing needs. The up to 10 L segment currently accounts for the largest market share.

Temperature-controlled Packaging for Pharmaceutical Use Insights

Based on use, the Temperature-controlled Packaging for Pharmaceutical Market is segmented into Single Use and Reusable. Single Use segment is expected to dominate the global temperature-controlled packaging for the pharmaceutical market during the forecast period. The market's largest usability segment is single use. The necessary containers that can only hold one shipment. Compared to reusable packaging systems, these containers offer a lighter and less expensive option. With the disposal of containers, the packaging system tends to generate packaging waste. The single-use container market is driven by its convenience, allowing for unlimited distribution, and eliminating the need to return containers to their original location. These containers are ideal for use in isolated areas where reverse logistics are impossible. In the forecast period, the market for single-use packaging solutions is likely to be driven by rising demand for pharmaceutical or biopharma goods (vaccines, cell and gene therapy, and clinical trials). Because of its disposable nature, the single-use category leads the market. However, due to sustainable steps made by pharmaceutical packaging specialists, the reusable category is expected to increase rapidly over the projection period.

Temperature-controlled Packaging for Pharmaceutical Medicine Type Insights

Based on medicine type, the Temperature-controlled Packaging for Pharmaceutical Market is segmented into Temperature Sensitive Pharmaceutical Drugs, Vaccine, and Regenerative Medicine. Temperature Sensitive Pharmaceutical Drugs medicine type segment is expected to dominate the global temperature-controlled packaging for the pharmaceutical market during the forecast period. Some drugs, such as insulin, are unaffected by cold or heat. To keep medicine safe, set strict packing and shipping requirements for temperature-sensitive products at express scripts. The manufacturer keeps drugs and US Pharmacopeia between 68-77°F (20-25°C). While ambient temperature refers to the air temperature in each environment, room temperature refers to the temperature range most people feel at ease. A thermometer determines ambient temperature, whereas room temperature is determined by feeling.

Temperature-controlled Packaging for Pharmaceutical End Use Industry Insights

Based on end use industry, the Temperature-controlled Packaging for Pharmaceutical Market is segmented into Pharmaceuticals and Clinical Trails. The pharmaceuticals end use industry segment is expected to dominate the global temperature-controlled packaging for the pharmaceutical market during the forecast period. The pharmaceutical segment will deliver higher performance than the latter throughout the forecast period. The pharmaceutical segment can perform well owing to the supply of drugs and blood to patients at hospitals and critical care centers. Pharma industries include products derived from synthetic or chemical processes (artificial sources). Medicines and other pharmaceuticals are among its offerings. Temperature variations, humidity, and other factors can cause pharmaceuticals to be damaged. As a result, the products are delivered worldwide in temperature-controlled packaging. The market for temperature-controlled packaging solutions is expected to be driven by rising pharmaceutical product demand during the forecast period.

Temperature-controlled Packaging for Pharmaceutical Regional Insights

The Temperature-controlled Packaging for Pharmaceutical Market, based on region, has been divided into North America, Europe, Asia Pacific, and Rest of the World. North America consists of US and Canada. Europe consists of UK, Germany, France, Italy, Spain, and Rest of Europe. Asia-Pacific consists of China, India, Japan, Sout Korea, Taiwan, Philippines, Indonesia, Thailand, Malaysia, Singapore, Hong Kong, Australia, and Rest Of Asia-Pacific. The rest of the world consists of the Middle East & Africa and South America.

North America accounted for the largest market share in 2023 and is expected to register the highest CAGR during the forecast period. Due to various lifestyle disorders, many patients, and high disposable income levels, North America is likely to be a highly profitable market during the forecast period. Pharmaceutical product safety regulations, as well as a growing geriatric population, may raise regional market demand. The market may benefit from bilateral trade agreements and increased international trade. Active systems have a considerable market in North America. Compared to the passive system, the active system provides the best level of temperature accuracy. For long-distance shipping, the active system maintains a constant temperature. The system is capable of effectively managing supply chain delays. With the availability of a power source, temperature excursions are less likely. The US Food and Drug Administration (FDA) has set a distribution practice regulation that stipulates that drugs must be supplied at the proper temperatures.

Asia Pacific held the second largest share in the market for global temperature-controlled packaging for pharmaceuticals and is anticipated to ascend at a revenue based CAGR over the forecast period. Because of the surge in infectious diseases and the necessity for cold chain solutions to preserve vaccines, APAC is thought to be tremendously profitable. Leading players operating in the Temperature-controlled Packaging for Pharmaceutical Market can target the highly potential Asian countries to maximize their financial revenues. As the market gets more concentrated, the region is expected to see more acquisitions. Due to the significant rise in chronic diseases and the increasing number of clinical trials in countries such as China and India, Asia-Pacific is predicted to develop at a higher rate during the projection period. Asia-Pacific has seen technological improvements on the back of its burgeoning population and increasing disease outbreaks.

The European Union (EU) authorities enforced a slew of new criteria for pharmaceutical packaging on fake pharmaceuticals in 2017, and Europe is predicted to grow significantly during the projection period. Anti-counterfeiting technologies, such as overt, covert, and forensic technology, have been applied by EU authorities for pharmaceutical packaging, resulting in pharmaceutical packaging companies in the region continuing to develop packaging methods and procedures. Regional packaging companies are using innovative strategies to improve their current portfolio. Bormioli Pharma S.p.A., an Italian glass and plastic packaging manufacturer announced in 2019 that it would use a more open, distributed approach to reach more consumers, merging internal R&D projects with start-ups and incubators. The company also announced that it would create a new organizational structure that would combine marketing and innovation functions. Such factors are expected to propel the regional market during the forecast period.

The Rest of World comprises of The Middle East and Africa and South America. The Middle East & Africa market is expected to rise significantly, owing to rising per capita disposable income, rising healthcare awareness, and rising pharmaceutical and drug consumption. Furthermore, the region is characterized by a growing manufacturing capacity and rising investments in the pharmaceutical packaging industry. The increasing pharmaceutical sector in Saudi Arabia is driving the pharmaceutical packaging market in the region. In South Africa, generic pharmaceuticals account for about half of the pharmaceutical market. This has resulted in a rise in the demand for drug and pharmaceutical packaging in South Africa. During the projected period, such factors are likely to fuel the region’s expansion of the Temperature-Controlled Packaging for Pharmaceutical market. Furthermore, the pharmaceutical sector in South America is expanding at a healthy rate, owing to many people being diagnosed with various ailments. Furthermore, the need for medical and healthcare centers is increasing, as is the consumption of pharmaceuticals. Brazil, Argentina, Chile, and Colombia contribute significantly to the region's total.

Figure 2: Temperature-controlled Packaging for Pharmaceutical Market Size By Region 2023 & 2032 (USD Million)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Global Temperature-controlled Packaging for Pharmaceutical Key Market Players & Competitive Insights

The global temperature-controlled packaging for the pharmaceutical market is characterized by many regional and local vendors. The regional market is highly competitive, with all the players continually competing to gain a larger market share. The vendors compete based on cost, product quality, reliability, and aftermarket services. Therefore, vendors must provide cost-effective and efficient products to survive and succeed in a competitive market environment.

Sonoco Thermosafe, UNITED PARCEL SERVICE AMERICA, INC, kaneka Corporation, DHL International GmbH, Deutsche Bahn AG and va-Q-tec AG, and few others. Global are the major players in the market, competing in terms of variety of applications and their components, as well as efficiency, reliability, affordability, and advanced technology. The primary focus of the players is to provide advanced products to aid in increasing adoption, which could help strengthen a country's growth. Although global players dominate the market, a few regional and other local players with a limited market share also have a prominent presence.

The major players focus on strengthening their global presence through mergers & acquisitions of local and regional players. These players are expected to expand their presence during the forecast period. Therefore, vendors must develop new technologies to stay at par with emerging technology trends that could affect the competitiveness of their product lines in the market.

Key Companies in the Temperature-controlled Packaging for Pharmaceutical Market include.

• Sonoco Thermosafe


• UNITED PARCEL SERVICE AMERICA, INC


• kaneka Corporation


• DHL International GmbH


• Deutsche Bahn AG


• Cold Chain Technologies, LLC


• EMBALL’ISO


• Inmark, LLC


• kuehne + nagel inc.


• CSafe Global


• va-Q-tec AG

Temperature-controlled Packaging for Pharmaceutical Industry Developments

• In 2022, CCT acquired Packaging Technology Group Inc (US). This acquisition will provide environmentally friendly and innovative thermal packaging solutions for the life sciences industry.


• In 2021, UPS opened a new cold chain packaging center in Kentucky (US) to serve its global healthcare logistics customers. This expansion will help manage the growing number of temperature-sensitive biologic drugs and currently developing cell and gene treatments.


• In 2020, Sonoco ThermoSafe signed an agreement with Asiana Airlines Inc. (Seoul) for leasing the new Pegasus ULD temperature-controlled bulk shipping container. This agreement will provide pharmaceutical freight forwarders access to Pegasus ULD containers directly from Asiana Airlines.

Temperature-controlled Packaging for Pharmaceutical Market Segmentation

Global Temperature-controlled Packaging for Pharmaceutical Product Outlook (USD Million, 2018-2032)

• Shippers


• Containers

Global Temperature-controlled Packaging for Pharmaceutical Type Outlook (USD Million, 2018-2032)

• Active System


• Passive System

Global Temperature-controlled Packaging for Pharmaceutical Temperature Range Outlook (USD Million, 2018-2032)

• -20°C AND BELOW


• -20°C TO 0°C


• 2°C TO 8°C


• 8°C TO 25°C


• ABOVE 25°C

Global Temperature-controlled Packaging for Pharmaceutical Payload Capacity Outlook (USD Million, 2018-2032)

• UP TO 10 L


• 10 L - 20 L


• 20 L - 40 L


• 40 L - 150 L


• ABOVE 150 L

Global Temperature-controlled Packaging for Pharmaceutical Use Outlook (USD Million, 2018-2032)

• Single Use


• Reusable

Global Temperature-controlled Packaging for Pharmaceutical Medicine Type Outlook (USD Million, 2018-2032)

• Temperature Sensitive Pharmaceutical Drugs


• Vaccine


• Regenerative Medicine

Global Temperature-controlled Packaging for Pharmaceutical End-use Industry Outlook (USD Million, 2018-2032)

• Pharmaceuticals


• Clinical Trails

Temperature-controlled Packaging for Pharmaceutical Market Regional Outlook

• 
  North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• 
  Europe
  
  
  
  • UK
  
  
  • Germany
  
  
  • Italy
  
  
  • France
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• 
  Asia-Pacific
  
  
  
  • China
  
  
  • India
  
  
  • Japan
  
  
  • South Korea
  
  
  • Taiwan
  
  
  • Philippines
  
  
  • Indonesia
  
  
  • Thailand
  
  
  • Malaysia
  
  
  • Singapore
  
  
  • Hong Kong
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• 
  Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • South America